Tags: Drug.

PRX-07034 is a selective 5-HT6 receptor antagonist. It has cognition and memory-enhancing properties and potently decreases food intake and body weight in rodents. PRX-07034 was under development by Epix Pharmaceuticals for the treatment of obesity and cognitive impairment associated with Alzheimer’s disease and schizophrenia but upon the company collapsing due to lack of funds the compound was auctioned to another corporation.

PRX-07034_structure.png
ATC prefix
none
CAS number
?
IUPAC name
N-[1-(5-chloro-23-dimethoxyphenyl)ethyl]-2-methylsulfonyl-5-piperazin-1-ylaniline
PubChem
11532574

Loading...

This page contains content from the copyrighted Wikipedia article "PRX-07034"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.